Lycia Therapeutics LYCA
Lycia Therapeutics files for IPO
Securities offering
- Form
- S-1
- Filed
- Importance
- Notable
- Accession
- 0001628280-26-064973
- Offers common stock for initial public offering
- Plans to list on Nasdaq under LYCA
- Underwriters include Jefferies, TD Cowen, Evercore ISI, Guggenheim Securities
Written from the S-1 on EDGAR. Check the filing before you rely on it.
Similar companies
Same SIC code (2836) and public float not reported.
- Adaptimmune Therapeutics ADAP
- Adverum Biotechnologies ADVM
- AgomAb Therapeutics AGMB
- Alvotech ALVO
- Argenx ARGX